Matthew Foy

Matthew is a partner at SR One in London.

Matthew joined SR One’s London office in 2011. Previously he was a Vice President at Greenhill & Co, an M&A Investment Bank and Private Equity firm in New York. His portfolio companies include Asceneuron, AtoxBio, Progenitor, PsiOxus, Puridify and VHSquared.

Matthew studied Molecular Biology at The University of Oxford; Drug Discovery at UCL; Corporate Finance at The London Business School and holds various FSA & SEC qualifications.